Man GLG ABS G Corporate Acc
|Bid Price||-||Offer Price||-|
|Mid Price||GBX 1,478.49||Day Change||GBX +0.27 (0.02%)|
|Price Date||19 Oct 2016||Crown Rating|
|Shares Class||Inc.||Yield||2.46 %|
|Total Expense Ratio||0.00||Fund Size||103,329,918.00|
|Launch Date||27/06/2006||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.25||Sector||IMA UK Equity Income|
|Min Investment (£)||0.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00B120G958||Min TopUp (£)||0.00|
The Company seeks over the medium term to provide investors with capital appreciation.To achieve its objective, the Company will invest primarily either directly or indirectly, in asset-backed securities, mortgage-backed securities, fixed and floating rate securities (such as government or corporate bonds), index-linked securities, derivatives (including credit derivatives and foreign exchange derivative contracts), structured credit instruments, money market instruments, deposits, and cash or cash equivalents, globally.
Sarah joined Man GLG (‘GLG’) in January 2008 and is an ABS asset manager. Prior to that, she spent seven years at Morgan Stanley where she was Head of European ABS research. Sarah has a PhD in Biochemistry from the University of London.